Transcutaneous auricular vagus nerve stimulation prevents postoperative delirium in elderly patients (VNSTAR): protocol for a multicentre, randomised controlled trial
- PMID: 40447430
- PMCID: PMC12128425
- DOI: 10.1136/bmjopen-2025-099736
Transcutaneous auricular vagus nerve stimulation prevents postoperative delirium in elderly patients (VNSTAR): protocol for a multicentre, randomised controlled trial
Abstract
Introduction: Postoperative delirium (POD) is a common complication in elderly patients and is closely associated with delayed recovery, prolonged hospital stays, increased mortality rates and increased medical expenses. Vagus nerve stimulation, a novel technique in the field of neuroscience, has demonstrated remarkable therapeutic potential in improving neurocognitive disorders. However, its applicability in ameliorating neurocognitive dysfunctions that arise during the perioperative period remains unclear. To date, no large prospective, randomised controlled studies have explored the effects of vagus nerve stimulation on POD.
Method and analysis: This study is a multicentre, double-blind, parallel, randomised controlled trial. It aims to explore the preventative effects of transcutaneous auricular vagus nerve stimulation on POD in elderly patients who are scheduled for elective surgery at several medical institutions in China from 2024 to 2027. The estimated sample size is 1776, with half of the patients randomly assigned to receive prophylactic standard transauricular auricular vagus nerve stimulation during the perioperative period (allocation ratio 1:1). The primary outcome measure is the incidence of POD within 5 days after surgery.
Ethics and dissemination: This study was approved by the Ethics Committee of Beijing Tiantan Hospital, Capital Medical University and adheres to the principles of the Declaration of Helsinki. The protocol was written in accordance with the 2013 Standard Protocol Items: Recommendations for Interventional Trials guidelines. The results of this study will be published in a peer-reviewed journal and presented at national or international conferences.
Trial registration number: NCT06421077.
Keywords: ANAESTHETICS; Cognition; Delirium.
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Effects of transcutaneous auricular vagus nerve stimulation on postoperative delirium in older patients with hip fracture: protocol for a randomised controlled trial.BMJ Open. 2025 Feb 20;15(2):e092413. doi: 10.1136/bmjopen-2024-092413. BMJ Open. 2025. PMID: 39979049 Free PMC article.
-
'Transauricular vagus nerve stimulation' for prevention of postoperative delirium in elderly patients undergoing major surgery: a study protocol for a multicentre, participant-blinded and assessor-blinded, randomised, controlled trial.BMJ Open. 2025 Apr 5;15(4):e093647. doi: 10.1136/bmjopen-2024-093647. BMJ Open. 2025. PMID: 40187777 Free PMC article.
-
Single-centre, randomised and double-blind clinical trial on the efficacy of transcutaneous auricular vagus nerve stimulation in preventing and treating primary headache in children and adolescents: a study protocol.BMJ Open. 2025 Mar 12;15(3):e092692. doi: 10.1136/bmjopen-2024-092692. BMJ Open. 2025. PMID: 40074270 Free PMC article.
-
Transcutaneous auricular vagal nerve stimulation for consciousness recovery in patients with prolonged disorders of consciousness (TAVREC): study protocol for a multicenter, triple-blind, randomized controlled trial in China.BMJ Open. 2024 May 31;14(5):e083888. doi: 10.1136/bmjopen-2024-083888. BMJ Open. 2024. PMID: 38821572 Free PMC article.
-
Lessons learned from transcutaneous vagus nerve stimulation (tVNS).Epilepsy Res. 2019 Jul;153:83-84. doi: 10.1016/j.eplepsyres.2019.02.015. Epub 2019 Feb 26. Epilepsy Res. 2019. PMID: 30952581 Review.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical